192 related articles for article (PubMed ID: 17667443)
1. Sciatic nerve neurolymphomatosis - extent and therapy response assessment with PET/CT.
Strobel K; Fischer K; Hany TF; Poryazova R; Jung HH
Clin Nucl Med; 2007 Aug; 32(8):646-8. PubMed ID: 17667443
[TBL] [Abstract][Full Text] [Related]
2. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.
von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M
Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723
[TBL] [Abstract][Full Text] [Related]
3. Neurolymphomatosis detected by (18)F-FDG PET/CT scan - a case report.
Czepczyński R; Guzikowska-Ruszkowska I; Sowiński J
Nucl Med Rev Cent East Eur; 2008; 11(2):73-5. PubMed ID: 19585459
[TBL] [Abstract][Full Text] [Related]
4. Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
Kasamon YL; Jones RJ; Wahl RL
J Nucl Med; 2007 Jan; 48 Suppl 1():19S-27S. PubMed ID: 17204717
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin's lymphoma.
Yamane T; Daimaru O; Ito S; Nagata T; Yoshiya K; Fukaya N; Ito S; Imai T; Uchida H
Ann Nucl Med; 2008 Oct; 22(8):719-22. PubMed ID: 18982476
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
Lin EC
Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
[TBL] [Abstract][Full Text] [Related]
7. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
9. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease.
Querellou S; Valette F; Bodet-Milin C; Oudoux A; Carlier T; Harousseau JL; Chatal JF; Couturier O
Ann Hematol; 2006 Nov; 85(11):759-67. PubMed ID: 16871391
[TBL] [Abstract][Full Text] [Related]
11. PET/CT for therapy response assessment in lymphoma.
Hutchings M; Barrington SF
J Nucl Med; 2009 May; 50 Suppl 1():21S-30S. PubMed ID: 19380407
[TBL] [Abstract][Full Text] [Related]
12. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study.
Belakhlef A; Jani C; Church C; Fraser R; Lakhanpal S
Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666
[TBL] [Abstract][Full Text] [Related]
13. Fluorothymidine PET/CT in neurolymphomatosis.
Biswal CK; Mittal BR; Shukla J; Vatsa R; Bhattacharya A; Prabhakar S
Clin Nucl Med; 2015 May; 40(5):e290-2. PubMed ID: 25546221
[TBL] [Abstract][Full Text] [Related]
14. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging.
Dong Q; Wong KK; Avram AM
Clin Nucl Med; 2008 Jan; 33(1):30-1. PubMed ID: 18097253
[TBL] [Abstract][Full Text] [Related]
15. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
[TBL] [Abstract][Full Text] [Related]
16. [Usefulness of FDG-PET in monitoring effects of the modality therapy for central nervous system malignant lymphoma: report of three cases].
Masada T; Matsumoto Y; Kawai N; Tamiya T; Nagao S
No Shinkei Geka; 2004 Aug; 32(8):859-64. PubMed ID: 15478653
[TBL] [Abstract][Full Text] [Related]
17. The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumours: long-term outcome of treatment with imatinib mesylate.
Goerres GW; Stupp R; Barghouth G; Hany TF; Pestalozzi B; Dizendorf E; Schnyder P; Luthi F; von Schulthess GK; Leyvraz S
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):153-62. PubMed ID: 15690223
[TBL] [Abstract][Full Text] [Related]
18. Image of the month. Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CT.
Paone G; Itti E; Capacchione D; Ortonne N; Brugières P; Evangelista E; Kallel F; Lefaucheur JP; Créange A; Meignan M
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1711-2. PubMed ID: 17673998
[No Abstract] [Full Text] [Related]
19. [Neurolymphomatosis of the sciatic nerve diagnosed by FDG-PET/CT].
Usami M; Murase K; Takada K; Iijima K; Yoshida M; Tatekoshi A; Hashimoto A; Iyama S; Sato T; Kobune M; Takimoto R; Kaya M; Yamashita T; Morita R; Hasegawa T; Kato J
Rinsho Ketsueki; 2016 Jan; 57(1):52-5. PubMed ID: 26861105
[TBL] [Abstract][Full Text] [Related]
20. Primary multifocal lymphoma of peripheral nervous system: case report and review of the literature.
Del Grande A; Sabatelli M; Luigetti M; Conte A; Granata G; Rufini V; Del Ciello A; Gaudino S; Fernandez E; Hohaus S; Coli A; Lauriola L
Muscle Nerve; 2014 Dec; 50(6):1016-22. PubMed ID: 25088432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]